In the early atherosclerosis group, daily oral administration of both doses of SEE and placebo for 8 consecutive weeks to NZWR reflected insignificant effects on some biochemical profiles, such as serum creatinine, AST, ALP, ALT, and GGT compared to pre-treatment. The gene discussed is GPT; the disease is atherosclerosis.